Synendos receives EMA nod for brain therapy
18th January 2024 Uncategorised 0Company is focused on endocannabinoid system treatments
More: Synendos receives EMA nod for brain therapy
Source: News
Company is focused on endocannabinoid system treatments
More: Synendos receives EMA nod for brain therapy
Source: News
© 1994 - 2026 B.M. Pharmaceuticals